LIFE SCIENCES
Life Sciences 25
Genzyme said a pill to treat Gaucher disease showed promise in a clinical trial; regulators approved a combination of Millennium and J&J drugs to treat multiple myeloma.
| LAST | MARKET CAP | LAST | PCT. | ||||
| NO. | WEEK | COMPANY | TICKER | (MILLIONS) | PRICE | CHANGE | |
| 1 | 1 | Boston Scientific Corp. | BSX | $22,901 | $15.44 | -2.6% | |
| 2 | 2 | Thermo Fisher Scientific | TMO | $22,628 | $53.63 | 0.0% | |
| 3 | 3 | Genzyme Corp. | GENZ | $16,638 | $63.01 | -2.7% | |
| 4 | 4 | Biogen Idec | BIIB | $15,891 | $46.38 | -0.6% | |
| 5 | 5 | Waters Corp. | WAT | $6,193 | $61.38 | 1.8% | |
| 6 | 6 | Sepracor | SEPR | $4,970 | $46.70 | -12.7% | |
| 7 | 9 | Vertex Pharmaceuticals | VRTX | $4,121 | $31.46 | 4.6% | |
| 8 | 7 | Millipore Corp. | MIL | $4,048 | $74.99 | -2.1% | |
| 9 | 8 | Cytyc Corp. | CYTC | $4,023 | $35.05 | 0.9% | |
| 10 | 10 | Millennium Pharmaceuticals | MLNM | $3,507 | $10.92 | 1.4% | |
| 11 | 11 | Charles River Laboratories | CRL | $3,437 | $51.07 | 1.3% | |
| 12 | 12 | Hologic | HOLX | $3,105 | $57.61 | -3.8% | |
| 13 | 13 | PerkinElmer | PKI | $3,060 | $25.55 | 0.6% | |
| 14 | 14 | Inverness Medical Innovations | IMA | $1,852 | $39.75 | -3.1% | |
| 15 | 15 | Alkermes | ALKS | $1,724 | $17.08 | 3.2% | |
| 16 | 16 | Haemonetics Corp. | HAE | $1,294 | $48.99 | -0.6% | |
| 17 | 17 | Cubist Pharmaceuticals | CBST | $1,172 | $21.18 | 0.2% | |
| 18 | 18 | Parexel International Corp. | PRXL | $1,105 | $39.72 | -1.0% | |
| 19 | 19 | Bruker BioSciences Corp. | BRKR | $934 | $8.87 | -1.7% | |
| 20 | 21 | PolyMedica Corp. | PLMD | $917 | $40.55 | -0.2% | |
| 21 | 20 | Advanced Magnetics | AMAG | $895 | $62.86 | -5.3% | |
| 22 | 22 | Palomar Medical Technologies | PMTI | $722 | $39.38 | -1.7% | |
| 23 | 23 | Alnylam Pharmaceuticals | ALNY | $621 | $16.53 | -5.4% | |
| 24 | 24 | Phase Forward | PFWD | $549 | $15.41 | -1.2% | |
| 25 | 25 | Indevus Pharmaceuticals | IDEV | $548 | $7.41 | 1.0% |
The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price-weighted indexes of all technology and life sciences stocks in the state. Listed above are the top companies, ranked by market value, in each sector. Asterisks indicate a stock that has moved five places or more in the last week. For up-to-the-minute rankings and stock prices, visit boston.com/business. 